According to the recent research report titled ‘Global Clinical Trials Matching Software Market Size study, by Deployment Type (Web & Cloud Based, On-premise), End Use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), and Regional Forecasts 2022-2028’ available with MarketStudyReport, global clinical trials matching software market accounted for USD 132.8 million in 2021 and  is anticipated to register 12.07% CAGR through 2028, simultaneously reaching USD 286.5 million by the end of forecast duration.

Factors such as surge in several clinical trials globally, rising digitization of the healthcare sector, growing prevalence of infectious and chronic diseases, increasing R&D funding activities, and mounting outsourcing activities of clinical research are together driving the global clinical trials matching software market growth.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5110016/  

For instance, the number of COVID-19 studies registered worldwide was projected to be just 260 trials in April 2020, but as of March 2021, the number of trials has climbed to 4,992 trials, according to ClinicalTrials.gov.

By locating potential studies and, in some cases, offering extra support services like instructional materials or staff who can assist patients, clinical trial matching software assists patients and their proxies (such as carers and providers) in enrolling in clinical trials.

However, high implementation & maintenance costs related to clinical trials matching solutions is likely to be a significant challenge to the market's expansion through 2028.

The global clinical trials matching software market sphere is segmented into deployment type, end-user landscape, and geographical terrain. By deployment type, the market is split into on-premises and web & cloud-based segments.

Based on end-user scope, this marketplace is segregated into pharmaceutical & biotechnology companies, medical device firms, and CROs.

The regional landscape of this industry’s vertical spans North America, Asia Pacific, North America, Europe, and the rest of the world. Asia-Pacific market is predicted to record significant growth during the study timeframe owing to the increasing healthcare expenditure in the region.

Furthermore, North America currently leads in terms of market share and is anticipated to showcase considerable growth through forecast duration owing to the continuous clinical trials activities.

IBM Clinical Development, Dacima Software Inc., Antidote Technologies Inc., Yprime LLC, Clinical Trials Mobile Application, DZS Clinical Services, SSS International Clinical Research, MasterControl Inc., Advarra, and Aris Global are some of the leading companies in global clinical trials matching software industry space.